| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | HCG Plus | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | HCG Plus | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | Drug Facts | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | Drug Facts | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | Oral HCG Homeopathic | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | Oral HCG Homeopathic | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) ® | 2 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) ® | 2 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | Novolin N NPH, Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL | 2 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | Novolin N NPH, Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL | 2 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | These highlights do not include all the information needed to use Novolin R safely and effectively. See full prescribing information for Novolin R. Initial U.S. Approval: 1991 Novolin R (Regular, Human Insulin [rDNA origin] USP) solution for subcutaneous or intravenous use ® | 2 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | These highlights do not include all the information needed to use Novolin R safely and effectively. See full prescribing information for Novolin R. Initial U.S. Approval: 1991 Novolin R (Regular, Human Insulin [rDNA origin] USP) solution for subcutaneous or intravenous use ® | 2 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | Novolin ® 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) | 2 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | Novolin ® 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) | 2 | |
| insulin human | ACTIVE INGREDIENT | 1Y17CTI5SR | HUMULIN ® R REGULAR INSULIN HUMAN INJECTION, USP (rDNA ORIGIN)100 UNITS PER ML (U-100) | 2 | |
| insulin human | ACTIVE MOIETY | 1Y17CTI5SR | HUMULIN ® R REGULAR INSULIN HUMAN INJECTION, USP (rDNA ORIGIN)100 UNITS PER ML (U-100) | 2 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | 81f28314-31c8-4114-a4b3-336eb2094558 | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | 81f28314-31c8-4114-a4b3-336eb2094558 | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | 44863566-b55c-422d-adbd-5454a70b68a9 | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | 44863566-b55c-422d-adbd-5454a70b68a9 | 1 | |
| insulin human | ACTIVE MOIETY | 1Y17CTI5SR | EXUBERA ® (insulin human [rDNA origin]) Inhalation Powder EXUBERA ® Inhaler | 1 | |
| insulin human | ACTIVE INGREDIENT | 1Y17CTI5SR | EXUBERA ® (insulin human [rDNA origin]) Inhalation Powder EXUBERA ® Inhaler | 1 | |
| insulin human | ACTIVE MOIETY | 1Y17CTI5SR | HUMULIN R (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY
] | 22 | |
| insulin human | ACTIVE INGREDIENT | 1Y17CTI5SR | HUMULIN R (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY
] | 22 | |
| Insulin human | ACTIVE INGREDIENT | 1Y17CTI5SR | HUMULIN R U-500 (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY
] | 15 | |
| Insulin human | ACTIVE MOIETY | 1Y17CTI5SR | HUMULIN R U-500 (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY
] | 15 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | NOVOLIN N (HUMAN INSULIN) INJECTION, SUSPENSION [NOVO NORDISK] | 10 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | NOVOLIN N (HUMAN INSULIN) INJECTION, SUSPENSION [NOVO NORDISK] | 10 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [NOVO NORDISK] | 9 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [NOVO NORDISK] | 9 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | AFREZZA (INSULIN HUMAN) POWDER, METERED AFREZZA (INSULIN HUMAN) KIT [SANOFI-AVENTIS U.S. LLC] | 5 | |
| Insulin Human | ACTIVE MOIETY | 1Y17CTI5SR | AFREZZA (INSULIN HUMAN) POWDER, METERED AFREZZA (INSULIN HUMAN) KIT [SANOFI-AVENTIS U.S. LLC] | 5 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | HUMULIN 70/30 70/30 (INSULIN HUMAN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 | |
| Insulin human | ACTIVE INGREDIENT | 1Y17CTI5SR | HUMULIN 70/30 70/30 (INSULIN HUMAN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | HUMULIN 70/30 70/30 (INSULIN HUMAN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 | |
| Insulin human | ACTIVE INGREDIENT | 1Y17CTI5SR | HUMULIN 70/30 70/30 (INSULIN HUMAN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | LEAN LOVE (ASCLEPIAS VINCETOXICUM, ECHINACEA (ANGUSTIFOLIA), HYPOTHALAMUS (SUIS), BRAIN (SUIS), HEPAR SUIS, METHYLCOBALAMIN, PANCREAS SUIS, KIDNEY (SUIS), STOMACH (SUIS),) LIQUID [INTENTIONAL NOURISHMENT] | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | LEAN LOVE (ASCLEPIAS VINCETOXICUM, ECHINACEA (ANGUSTIFOLIA), HYPOTHALAMUS (SUIS), BRAIN (SUIS), HEPAR SUIS, METHYLCOBALAMIN, PANCREAS SUIS, KIDNEY (SUIS), STOMACH (SUIS),) LIQUID [INTENTIONAL NOURISHMENT] | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | NOVOLIN70/30 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | NOVOLIN70/30 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | NOVOLIN70/30 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | NOVOLIN70/30 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | PROFESSIONAL WEIGHT MAINTENANCE (ASCLEPIAS VINCETOXICUM, ECHINACEA (ANGUSTIFOLIA), HYPOTHALAMUS (SUIS), HEPAR SUIS, KIDNEY (SUIS), METHYLCOBALAMIN, GAMBOGIA, GRAPHITES, NUX VOMICA,) LIQUID [DR. DONNA RESTIVO DC] | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | PROFESSIONAL WEIGHT MAINTENANCE (ASCLEPIAS VINCETOXICUM, ECHINACEA (ANGUSTIFOLIA), HYPOTHALAMUS (SUIS), HEPAR SUIS, KIDNEY (SUIS), METHYLCOBALAMIN, GAMBOGIA, GRAPHITES, NUX VOMICA,) LIQUID [DR. DONNA RESTIVO DC] | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | PROZINC (PROTAMINE ZINC RECOMBINANT HUMAN INSULIN) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | PROZINC (PROTAMINE ZINC RECOMBINANT HUMAN INSULIN) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 1 | |
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | WLP40 (ASCLEPIAS VINCETOXICUM, ECHINACEA (ANGUSTIFOLIA), HYPOTHALAMUS (SUIS), BRAIN (SUIS), HEPAR SUIS, KIDNEY (SUIS), METHYLCOBALAMIN, PANCREAS SUIS,) LIQUID [DR.DONNA RESIVO DC] | 1 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | WLP40 (ASCLEPIAS VINCETOXICUM, ECHINACEA (ANGUSTIFOLIA), HYPOTHALAMUS (SUIS), BRAIN (SUIS), HEPAR SUIS, KIDNEY (SUIS), METHYLCOBALAMIN, PANCREAS SUIS,) LIQUID [DR.DONNA RESIVO DC] | 1 | |